Groove Botanicals Inc reported a nominal operating loss in QQ3 2025, with no disclosed revenue for the quarter. The company posted an operating loss of 33,031 USD and a net loss of 33,031 USD, accompanied by SG&A expenses of 33,031 USD. The company’s cash burn from operations was 25,861 USD, leaving cash and cash equivalents of 1,251 USD at quarter-end. The balance sheet signals acute liquidity stress, with total current liabilities of 1,028,546 USD and total assets of 4,733 USD, producing a current ratio of 0.0046 and a negative stockholders’ equity of -1,023,813 USD. Free cash flow for QQ3 2025 was -25,861 USD, and the company shows a negative earnings per share (EPS) of -0.0015 USD. Management commentary is not provided in the data set; no earnings transcript is available for QQ3 2025, limiting insight into strategic pivots or near-term guidance. Investors should treat this as a high-risk, high-uncertainty report until more granular revenue data, updated guidance, and a credible path to liquidity are disclosed.